Brett Reggio, PhD , HCLD, Laboratory Director
RCC's Infertility Specialist Staff
Brett Reggio, PhD, HCLD, is the Laboratory Director at RCC. Dr. Reggio graduated from Tulane University in New Orleans with a BS in Biology in 1992, and then moved to Baton Rouge to pursue his MS (1997) and PhD (2002) degrees at Louisiana State University (LSU) in the Department of Animal Science.
While at LSU, Dr. Reggio concentrated on in vitro embryo culture systems and in producing cloned transgenic dairy animals capable of generating valuable pharmaceutical proteins in their milk, working closely with Genzyme Transgenics Corporation Biotherapeutics.
One of these therapeutics (ATryn) was approved in August 2006 by the European Commission for use in patients with hereditary antithrombin deficiency undergoing surgical procedures.
This was the first approval in the world of a therapeutic protein produced from a transgenic animal. In 2009, ATryn made history by becoming the first biological product produced by genetically engineered animals to be granted FDA approval in the United States.
After leaving LSU in 2003, Dr. Reggio moved to Washington, DC to join the IVF team at Walter Reed Army Medical Center in order to use his skills in a clinical IVF setting. In 2005, Dr. Reggio became the IVF Laboratory Supervisor at the Northern California Fertility Medical Center in Roseville, California. He was then recruited to join the Reproductive Care Center in February 2007 as the Director of Research and Development.
Dr. Reggio completed his High Complexity Clinical Laboratory Director (HCLD) certification through the American Board of Bioanalysis (ABB) and became the Reproductive Care Center laboratory director in August 2008. Dr. Reggio is also a member of the College of Reproductive Biology (CRB) administered through the American Association of Bioanalysts’ (AAB). He is a member of the American Society of Reproductive Medicine (ASRM) and the European Society of Human Reproductive and Embryology (ESHRE).
Sasha Hennessy Reggio, BS, TS, Senior Embryologist
Sasha Hennessy Reggio is the Senior Embryologist at RCC, and has been practicing embryology since 1993. She earned her BS degree in Biology from George Mason University in 1994, and was employed with Genetics and IVF Institute in Fairfax, VA for 7 years, working as a certified cytogeneticist and embryologist.
In 2000, Sasha joined The A.R.T. Institute of Washington, Inc. at Walter Reed National Military Medical Center in Bethesda, MD (formally known as Walter Reed Army Medical Center in Washington, DC), and was promoted to Senior Embryologist. During her 13 years at Walter Reed, she was responsible for maintaining the day-to-day operations of this busy IVF unit, and facilitated the training of fellows from the Combined Federal Fellowship in Reproductive Endocrinology and Infertility during their rotation through the IVF clinic.
In 2013, Sasha was recruited by RCC to join the IVF team as Senior Embryologist. She is a certified Technical Supervisor (TS) in Embryology, which is administered by the American Board of Bioanalysts (ABB). She also upholds her certification in cytogenetics with the American Society of Clinical Pathologists (ASCP), and is a member of the American Society of Reproductive Medicine (ASRM).
Benjamin Sessions, PhD
Benjamin R Sessions, PhD, is an embryologist at RCC. Dr. Sessions earned his BS in Biology and Chemistry in 1999, and obtained his MS (2004) and PhD (2012) in Animal Science from Utah State University.
After completion of his PhD, Dr. Sessions worked as a Research Assistant Professor in the Department of Animal, Dairy, and Veterinary Sciences at Utah State University where he taught laboratory based biotechnology courses for both undergraduate and graduate students in addition to being a member of the USU somatic cell nuclear transfer team where he assisted in producing clones of cattle, sheep, goats, and mules.
While at USU he gained extensive experience performing oocyte aspiration and maturation, in vitro fertilization, in vitro embryo culture, and embryo cryopreservation in the bovine model. He has published numerous abstracts and scientific papers and presented his research findings at many national and international scientific conferences. Dr. Sessions’ research focused on improving the embryo culture conditions of bovine nuclear transfer and IVF embryos as well as elucidating the key signaling pathways involved in oocyte activation and characterizing the epigenetic reprogramming profiles of key genes required for proper bovine embryonic development.
Dr. Sessions desired to use his knowledge and experience to assist patients in obtaining their dreams of having a family and as a result joined RCC in 2014. He is a member of the American Society of Reproductive Medicine (ASRM) and the European Society of Human Reproductive and Embryology (ESHRE).